Hyperhomocyst(e)inaemia: an independent risk factor for intermittent claudication
Hyperhomocyst(e)inaemia: an independent risk factor for intermittent claudication
复制标题
高同型半胱氨酸血症:间歇性跛行的独立危险因素
DOI:
10.1111/j.1365-2796.1992.tb00535.x
复制
发表时间:
1992
影响因子:
11.1
通讯作者:
A. Olsson
中科院分区:
文献类型:
--
作者:
J. Mölgaard;M. Malinow;C. Lassvik;A. Holm;B. Upson;A. Olsson
Abstract. The aim of this study was to test the question of hyperhomocyst(e)inaemia as a risk factor for intermittent claudication (IC) independent of other important risk factors for peripheral atherosclerotic disease, such as smoking, hypertension, diabetes mellitus, hypercholesterolaemia, hypertriglyceridaemia, low levels of high‐density‐lipoprotein (HDL) cholesterol and age. The study population was recruited from an epidemiological study in LinkÖping County, Sweden, where all middle‐aged men (n = 15253, 45–69 years of age) were screened for IC. Seventy‐eight subjects with verified IC and 98 healthy sex‐ and age‐matched controls were randomly selected. Plasma levels of homocyst(e)ine (including the sum of free and bound forms of homocysteine and their disulphide oxidation products, homocystine, and homocysteine‐cysteine mixed disulphide) were significantly higher (16.74 ± 5.45 μmol l−1, mean value ± SD, P = 0.0002) in IC subjects than in controls (13.80 ± 3.21 μmol l−1), with 23% of the claudicants above the 95th percentile for controls. Stepwise logistic regression analysis revealed that the difference in plasma homocyst(e)ine was independent of the other above‐mentioned risk factors. Moreover, the elevation of plasma homocyst(e)ine in claudicants was mainly confined to subjects with serum folate levels of < 11.0 nmol l−1. The results suggest that folic acid supplementation should be tried in IC subjects with hyperhomocyst(e)inaemia.
DOI:
10.1016/0005-2760(87)90139-1
发表时间:
1987
期刊:
Biochimica et biophysica acta
影响因子:
--
作者:
Parthasarathy,S
通讯作者:
Parthasarathy,S
影响因子:
37.8
作者:
MALINOW, MR;KANG, SS;UPSON, B
通讯作者:
UPSON, B